Arrowhead Pharmaceuticals
ARWR
#2055
Rank
NZ$16.11 B
Marketcap
NZ$115.12
Share price
0.30%
Change (1 day)
222.51%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): NZ$0.26 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.82 Billion. In 2024 the company made an earning of -NZ$1 Billion a decrease over its 2023 earnings that were of -NZ$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.26 B-126.46%
2024 -NZ$1 Billion112.45%
2023 -NZ$0.47 Billion87.79%
2022 -NZ$0.25 Billion-20.1%
2021 -NZ$0.32 Billion67.59%
2020 -NZ$0.19 Billion-347.53%
2019 NZ$75.36 M-245.59%
2018 -NZ$51.77 Million-13.17%
2017 -NZ$59.63 Million-52.28%
2016 -NZ$0.13 Billion-16.57%
2015 -NZ$0.15 Billion30.32%
2014 -NZ$0.12 Billion171.62%
2013 -NZ$42.31 Million16.56%
2012 -NZ$36.3 Million107.53%
2011 -NZ$17.49 Million
2008 -NZ$61.61 Million-8.07%
2007 -NZ$67.02 Million70.37%
2006 -NZ$39.34 Million122.51%
2005 -NZ$17.68 Million147.41%
2004 -NZ$7.15 Million2002.28%
2003 -NZ$0.34 Million-85.61%
2002 -NZ$2.37 Million1371.97%
2001 -NZ$0.17 Million-13.45%
2000 -NZ$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.79 B 22,893.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-NZ$5.23 Billion-2,332.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-52.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.2 Billion-183.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.21 B-7.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-NZ$0.18 Billion-176.72%๐Ÿ‡บ๐Ÿ‡ธ USA